CJC-1295 No-DAC vs MK-677 — mechanism, half-life, dosing, and research status compared. Which is right for your protocol?
CJC-1295 No-DAC (also called Modified GRF 1-29 or Mod GRF) is a short-acting GHRH (Growth Hormone-Releasing Hormone) analog consisting of the first 29 amino acids of endogenous GHRH with four amino acid substitutions to improve stability and receptor binding....
Calculate CJC-1295 No-DAC dose →MK-677 (ibutamoren) is an orally active, non-peptide ghrelin receptor agonist (GHS-R1a) that stimulates GH release from the pituitary without requiring injection. It was developed by Merck and advanced through Phase II trials for growth hormone deficiency, muscle wasting, and fra...
Calculate MK-677 dose →| Parameter | CJC-1295 No-DAC | MK-677 |
|---|---|---|
| Category | Growth Hormone & IGF | Growth Hormone & IGF |
| Research | Research Use | Phase II (Discontinued) |
| Half-Life | 30 minutes | ~24 hours |
| Typical Dose | 100–200 µg | 10–25 mg |
| Frequency | 2–3x daily | Once daily |
| Route | Subcutaneous | Oral |
| FDA Status | Not Approved | Not Approved |
Use ASCEND's free reconstitution calculator to get exact syringe draw amounts for your vial.
For research use only. Not medical advice. ASCEND does not conduct or endorse any specific research protocol. Always consult relevant scientific literature and regulatory guidelines.